Advanced Search

 

Study ID Status Title Patient Level Data
204791 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204792 Completed Determination of UVA Protection Factor (UVAPF) for a cosmetic product
204799 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204800 Terminated Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
204802 Withdrawn Clinical, Single-blind and Controlled Study of the Potential of Irritability and Cutaneous Sensitization (RIPT) of a Cosmetic product SB.
204803 Withdrawn Clinical, Single-blind and Controlled Study of the Potential of Irritability and Cutaneous Sensitization (RIPT) of a Cosmetic product SB.
204804 Withdrawn Clinical, Single-blind and Controlled Study of the Potential of Cutaneous Photosensitization and Phototoxicity of a cosmetic product SB
204805 Withdrawn Clinical, Single-blind and Controlled Study of the Potential of Cutaneous Photosensitization and Phototoxicity of a cosmetic product SB
204810 Withdrawn An observer-blind study to assess the safety, reactogenicity and immunogenicity of GSK Biologicals’ investigational RSV vaccine (GSK3003891A), in healthy pregnant women and infants born to vaccinated mothers
204812 Completed An observer-blind study to rank different formulations of GSK Biologicals’ investigational RSV vaccine (GSK3003891A) administered to healthy women
204813 Completed An observer-blind safety and reactogenicity study to assess GlaxoSmithKline (GSK) Biologicals’ investigational respiratory syncytial virus (RSV) vaccine (GSK3003891A) in healthy women Study Listed on ClinicalStudyDataRequest.com
204824 Terminated A Phase 2 Pilot, Multicenter, Single Arm Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GSK1070806 plus Standard of Care for the Prevention of Delayed Graft Function in Adult Subjects After Renal Transplantation
204836 Completed A 29-day, randomized, double-blinded, placebo-controlled, parallel-group, multi-center study to evaluate the efficacy, safety and pharmacokinetics of three-times weekly dosing of GSK1278863 in hemodialysis-dependent subjects with anemia associated with chronic kidney disease who are switched from a stable dose of an erythropoiesis-stimulating agent
204837 Recruiting A Phase 3 randomized, double-blind, active-controlled, parallel-group, multi-center study in hemodialysis participants with anemia of chronic kidney disease to evaluate the efficacy, safety and pharmacokinetics of three-times weekly dosing of daprodustat compared to recombinant human erythropoietin, following a switch from recombinant human erythropoietin or its analogs
204838 Recruiting A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive infants
204847 Terminated A Phase I, Randomized, Double-Blind (Sponsor Unblinded), Single-Center, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Single and Repeat Intravenous Doses of GSK3342830 in Healthy Adult Subjects
204851 Completed A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis
204853 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of GSK3191607 in Healthy Male Subjects Following Administration of [14C]-GSK3191607 Study Listed on ClinicalStudyDataRequest.com
204856 Completed A Phase I, Randomized, Placebo-Controlled, Double-Blind (sponsor unblind), Three Part Study to Evaluate the Safety, Tolerability, Preliminary PK and PD of Single and Repeat Oral Doses of GSK3008356 in Healthy Subjects and Obese Subjects
204860 Completed A double-blind (sponsor unblinded) study to investigate safety, tolerability, pharmacokinetics, pharmacodynamics and clinical effect of repeat dosing of GSK2646264 in cutaneous lupus erythematosus patients
204870 Completed A Clinical Study to Evaluate the Efficacy of an Experimental Mouthwash Formulation
204878 Recruiting Observational study to assess frailty of subjects during ZOSTER-006 and ZOSTER-022 and HZ efficacy, immunogenicity and safety of HZ/su by frailty status
204879 Terminated A Randomized, Open-label, Active-Controlled, Parallel-Group, Exploratory Study on the Effects of Repeated Doses of Albiglutide compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
204885 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Peach Beige, in subjects with all Skin Types Under Normal Usage Conditions
204888 Not yet recruiting HO-15-15503 - Qualitative Interviews and Survey: Understanding how the attributes of Relvar/Breo convey patient benefits – Asthma and COPD

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.